Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Precision medicine: The future of diagnostic approach to pulmonary hypertension?

Kedzierski P, Torbicki A.

Anatol J Cardiol. 2019 Sep;22(4):168-171. doi: 10.14744/AnatolJCardiol.2019.97820. Review.

2.

Data Base of pulmoNary hyPertension in the PoLish population (BNP-PL) - design of the registry.

Kopeć G, Kurzyna M, Mroczek E, Chrzanowski Ł, Mularek-Kubzdela T, Skoczylas I, Kuśmierczyk B, Pruszczyk P, Błaszczak P, Lewicka E, Karasek D, Mizia-Stec K, Tomaszewski M, Jacheć W, Ptaszyńska-Kopczyńska K, Peregud-Pogorzelska M, Doboszyńska A, Pawlak A, Gąsior Z, Zabłocka W, Ryczek R, Widejko-Pietkiewicz K, Waligóra M, Darocha S, Furdal M, Ciurzyński M, Kasprzak JD, Grabka M, Kwiatkowska J, Kamiński K, Hoffman P, Podolec P, Torbicki A.

Kardiol Pol. 2019 Sep 25. doi: 10.33963/KP.14988. [Epub ahead of print] No abstract available.

3.

Changes in Estimated Glomerular Filtration after Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Darocha S, Banaszkiewicz M, Pietrasik A, Siennicka A, Piorunek M, Grochowska E, Piłka M, Dobosiewicz A, Florczyk M, Pietura R, Torbicki A, Kurzyna M.

Cardiorenal Med. 2019 Sep 17:1-10. doi: 10.1159/000502254. [Epub ahead of print]

PMID:
31527376
4.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group .

Eur Heart J. 2019 Aug 31. pii: ehz405. doi: 10.1093/eurheartj/ehz405. [Epub ahead of print] No abstract available.

PMID:
31504429
5.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Authors/Task Force Members:, Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Áinle FN, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; Document Reviewers: Nazzareno Galié (CPG Review Coordinator) (Italy), J. Simon R. Gibbs (CPG Review Coordinator) (United Kingdom), Victor Aboyans (France), Walter Ageno (Italy), Stefan Agewall (Norway), Ana G. Almeida (Portugal), Felicita Andreotti (Italy), Emanuele Barbato (Italy), Johann Bauersachs (Germany), Andreas Baumbach (United Kingdom), Farzin Beygui (France), Jørn Carlsen (Denmark), Marco De Carlo (Italy), Marion Delcroix (Belgium), Victoria Delgado (Netherlands), Pilar Escribano Subias (Spain), Donna Fitzsimons (United Kingdom), Sean Gaine (Ireland), Samuel Z. Goldhaber (United States of America), Deepa Gopalan (United Kingdom), Gilbert Habib (France), Sigrun Halvorsen (Norway), David Jenkins (United Kingdom), Hugo A. Katus (Germany), Barbro Kjellström (Sweden), Mitja Lainscak (Slovenia), Patrizio Lancellotti (Belgium), Geraldine Lee (United Kingdom), Grégoire Le Gal (Canada), Emmanuel Messas (France), Joao Morais (Portugal), Steffen E. Petersen (United Kingdom), Anna Sonia Petronio (Italy), Massimo Francesco Piepoli (Italy), Susanna Price (United Kingdom), Marco Roffi (Switzerland), Aldo Salvi (Italy), Olivier Sanchez (France), Evgeny Shlyakhto (Russian Federation), Iain A. Simpson (United Kingdom), Stefan Stortecky (Switzerland), Matthias Thielmann (Germany), Anton Vonk Noordegraaf (Netherlands); Document Reviewers:.

Eur Respir J. 2019 Oct 9;54(3). pii: 1901647. doi: 10.1183/13993003.01647-2019. Print 2019 Sep. No abstract available.

PMID:
31473594
6.

The evolution of electrocardiographic signs of right ventricular overload after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Piłka M, Darocha S, Banaszkiewicz M, Florczyk M, Wieteska M, Dobosiewicz A, Mańczak M, Mańczak R, Pietrasik A, Pietura R, Torbicki A, Kurzyna M.

Pol Arch Intern Med. 2019 Aug 29;129(7-8):451-459. doi: 10.20452/pamw.14877. Epub 2019 Jun 25.

7.

Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases.

Torbicki A, Bacchi M, Delcroix M, Farber HW, Ghofrani HA, Hennessy B, Jansa P, Mehta S, Perchenet L, Pulido T, Rosenberg D, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Wei LJ, Channick R, Benza R.

Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005095. doi: 10.1161/CIRCOUTCOMES.118.005095.

PMID:
31109190
8.

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax.

Jacheć W, Tomasik A, Kurzyna M, Pietura R, Torbicki A, Głowacki J, Nowalany-Kozielska E, Wojciechowska C.

BMC Pulm Med. 2019 Apr 16;19(1):80. doi: 10.1186/s12890-019-0832-8.

9.

Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?

Gibbs JSR, Torbicki A.

Eur Respir J. 2019 Mar 28;53(3). pii: 1900197. doi: 10.1183/13993003.00197-2019. Print 2019 Mar. No abstract available.

PMID:
30923179
10.

Augmented reality and three-dimensional printing in percutaneous interventions on pulmonary arteries.

Witowski J, Darocha S, Kownacki Ł, Pietrasik A, Pietura R, Banaszkiewicz M, Kamiński J, Biederman A, Torbicki A, Kurzyna M.

Quant Imaging Med Surg. 2019 Jan;9(1):23-29. doi: 10.21037/qims.2018.09.08.

11.

Assessing the severity of acute pulmonary embolism: back to the future?

Torbicki A.

Eur Heart J. 2019 Mar 14;40(11):911-913. doi: 10.1093/eurheartj/ehz018.

PMID:
30726904
12.

Diagnosis of pulmonary hypertension.

Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, Oudiz R, Satoh T, Torres F, Torbicki A.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801904. doi: 10.1183/13993003.01904-2018. Print 2019 Jan.

13.

Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial.

Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, Halank M, Simkova I, Karlocai K, Steringer-Mascherbauer R, Samarzija M, Salobir B, Klepetko W, Lindner J, Lang IM.

Lancet Respir Med. 2019 Mar;7(3):239-248. doi: 10.1016/S2213-2600(18)30367-9. Epub 2018 Nov 23.

PMID:
30477763
14.

Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.

Young A, Nagaraja V, Basilious M, Habib M, Townsend W, Gladue H, Badesch D, Gibbs JSR, Gopalan D, Manes A, Oudiz R, Satoh T, Torbicki A, Torres F, McLaughlin V, Khanna D.

Semin Arthritis Rheum. 2019 Jun;48(6):1059-1067. doi: 10.1016/j.semarthrit.2018.10.010. Epub 2018 Oct 14.

PMID:
30415942
15.

Response to letter from dr Altmayer regarding publication "Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics".

Darocha S, Banaszkiewicz M, Pietrasik A, Piłka M, Florczyk M, Wieteska M, Dobosiewicz A, Szmit S, Torbicki A, Kurzyna M.

Int J Cardiol. 2019 Feb 1;276:240-241. doi: 10.1016/j.ijcard.2018.10.103. Epub 2018 Oct 30. No abstract available.

PMID:
30414750
16.

Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy.

Araszkiewicz A, Darocha S, Pietrasik A, Pietura R, Jankiewicz S, Banaszkiewicz M, Sławek-Szmyt S, Biederman A, Mularek-Kubzdela T, Lesiak M, Torbicki A, Kurzyna M.

Int J Cardiol. 2019 Mar 1;278:232-237. doi: 10.1016/j.ijcard.2018.10.066. Epub 2018 Oct 25.

PMID:
30409735
17.

Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study.

Agnelli G, Becattini C, Bauersachs R, Brenner B, Campanini M, Cohen A, Connors JM, Fontanella A, Gussoni G, Huisman MV, Lambert C, Meyer G, Muñoz A, Abreu de Sousa J, Torbicki A, Verso M, Vescovo G; Caravaggio Study Investigators.

Thromb Haemost. 2018 Sep;118(9):1668-1678. doi: 10.1055/s-0038-1668523. Epub 2018 Aug 13.

PMID:
30103252
18.

Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics.

Darocha S, Banaszkiewicz M, Pietrasik A, Piłka M, Florczyk M, Wieteska M, Dobosiewicz A, Szmit S, Torbicki A, Kurzyna M.

Int J Cardiol. 2018 Oct 15;269:283-288. doi: 10.1016/j.ijcard.2018.07.015. Epub 2018 Jul 3.

PMID:
30017517
19.

Pregnancy as a predictor of deviations from the recommended diagnostic pathway in women with suspected pulmonary embolism: ZATPOL registry data.

Fijałkowska A, Szczerba E, Szewczyk G, Budaj-Fidecka A, Burakowski J, Sobkowicz B, Nowowiejska-Wiewióra A, Opolski G, Torbicki A, Kurzyna M; Investigators ZATPOL Registry.

Arch Med Sci. 2018 Jun;14(4):838-845. doi: 10.5114/aoms.2017.70896. Epub 2017 Oct 20.

20.

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.

Souza R, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Torbicki A, Rubin LJ, Simonneau G.

PLoS One. 2018 Mar 28;13(3):e0193226. doi: 10.1371/journal.pone.0193226. eCollection 2018.

21.

Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis.

Darocha S, Wilk M, Walaszkowska-Czyż A, Kępski J, Mańczak R, Kurzyna M, Torbicki A, Szmit S.

In Vivo. 2018 Mar-Apr;32(2):373-379.

22.

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.

McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N.

J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010.

23.

The importance of psychosocial factors in management of pulmonary arterial hypertension patients.

Sobczak-Kaleta MA, Torbicki A, Kasprzak JD.

Kardiol Pol. 2018;76(3):529-535. doi: 10.5603/KP.a2018.0029. Epub 2018 Jan 19. Review. No abstract available.

24.

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?

Florczyk M, Wieteska M, Kurzyna M, Gościniak P, Pepke-Żaba J, Biederman A, Torbicki A.

Pulm Circ. 2018 Apr-Jun;8(2):2045893217749114. doi: 10.1177/2045893217749114. Epub 2017 Dec 18.

25.

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil.

Kurzyna M, Małaczyńska-Rajpold K, Koteja A, Pawlak A, Chrzanowski Ł, Furdal M, Gąsior Z, Jacheć W, Sobkowicz B, Norwa J, Mularek-Kubzdela T, Torbicki A.

BMC Pulm Med. 2017 Dec 2;17(1):162. doi: 10.1186/s12890-017-0474-7.

26.

Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.

Kacprzak A, Szturmowicz M, Burakowska B, Franczuk M, Kober J, Kurzyna M, Wilk M, Szmit S, Torbicki A, Kuś J.

Adv Respir Med. 2017;85(5):258-263. doi: 10.5603/ARM.a2017.0042. Epub 2017 Oct 30.

27.

Macitentan for treatment of CTEPH: why MERIT merits attention.

Torbicki A.

Lancet Respir Med. 2017 Oct;5(10):762-763. doi: 10.1016/S2213-2600(17)30342-9. Epub 2017 Sep 11. No abstract available. Erratum in: Lancet Respir Med. 2017 Oct;5(10 ):e30.

PMID:
28919198
28.

Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P, Kolh P, Agewall S, Bueno H, Coca A, De Borst GJ, Delgado V, Dick F, Erol C, Ferrini M, Kakkos S, Katus HA, Knuuti J, Lindholt J, Mattle H, Pieniazek P, Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J, Tokgozoglu L, Torbicki A, Tsakountakis N, Tuñón J, de Ceniga MV, Windecker S, Zamorano JL.

Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368. doi: 10.1016/j.ejvs.2017.07.018. Epub 2017 Aug 26. Review. No abstract available.

29.

Contemporary methods for the treatment of pulmonary embolism - is it prime-time for percutaneous interventions?

Kurzyna M, Pietrasik A, Opolski G, Torbicki A.

Kardiol Pol. 2017;75(11):1161-1170. doi: 10.5603/KP.a2017.0125. Epub 2017 Jul 17. Review. No abstract available.

30.

[A statement the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for CTEPH patients after acute pulmonary embolism].

Ciurzyński M, Kurzyna M, Kopeć G, Błaszczak P, Chrzanowski Ł, Kamiński K, Mizia-Stec K, Mularek-Kubzdela T, Mroczek E, Biederman A, Pruszczyk P, Torbicki A.

Kardiol Pol. 2017;75(6):620-627. doi: 10.5603/KP.2017.0110. Polish.

31.

Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience.

Kurzyna M, Darocha S, Pietura R, Pietrasik A, Norwa J, Mańczak R, Wieteska M, Biederman A, Matsubara H, Torbicki A.

Kardiol Pol. 2017;75(7):645-654. doi: 10.5603/KP.a2017.0091. Epub 2017 May 29.

32.

The pathophysiology of chronic thromboembolic pulmonary hypertension.

Simonneau G, Torbicki A, Dorfmüller P, Kim N.

Eur Respir Rev. 2017 Mar 29;26(143). pii: 160112. doi: 10.1183/16000617.0112-2016. Print 2017 Mar 31. Review.

33.

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani HA, Le Brun FO, Mehta S, Perchenet L, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A.

Eur Heart J. 2017 Apr 14;38(15):1147-1155. doi: 10.1093/eurheartj/ehx025.

34.

Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function.

Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MPA, Büller HR, Elias A, Farge D, Konstantinides S, Palareti G, Prandoni P, Righini M, Torbicki A, Vlachopoulos C, Brodmann M.

Eur Heart J. 2018 Dec 14;39(47):4208-4218. doi: 10.1093/eurheartj/ehx003. No abstract available.

PMID:
28329262
35.

Improvement in Quality of Life and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension Treated With Balloon Pulmonary Angioplasty.

Darocha S, Pietura R, Pietrasik A, Norwa J, Dobosiewicz A, Piłka M, Florczyk M, Biederman A, Torbicki A, Kurzyna M.

Circ J. 2017 Mar 24;81(4):552-557. doi: 10.1253/circj.CJ-16-1075. Epub 2017 Feb 1.

36.

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Kim NH, D'Armini AM, Grimminger F, Grünig E, Hoeper MM, Jansa P, Mayer E, Neurohr C, Simonneau G, Torbicki A, Wang C, Fritsch A, Davie N, Ghofrani HA.

Heart. 2017 Apr;103(8):599-606. doi: 10.1136/heartjnl-2016-309621. Epub 2016 Dec 23.

37.

[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines].

Zamorano JL, Lancellotti P, Muñoz DR, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Fernandez TL, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM.

Kardiol Pol. 2016;74(11):1193-1233. doi: 10.5603/KP.2016.0156. Polish. No abstract available.

38.

Prognostic Significance of Right Heart Thrombi in Patients With Acute Symptomatic Pulmonary Embolism: Systematic Review and Meta-analysis.

Barrios D, Rosa-Salazar V, Morillo R, Nieto R, Fernández S, Zamorano JL, Monreal M, Torbicki A, Yusen RD, Jiménez D.

Chest. 2017 Feb;151(2):409-416. doi: 10.1016/j.chest.2016.09.038. Epub 2016 Oct 14. Review.

PMID:
27746202
39.

The "bouncing" catheter.

Malaczynska-Rajpold K, Kurzyna M, Koteja A, Torbicki A, Mularek-Kubzdela T.

Cardiol J. 2016;23(5):552-553. doi: 10.5603/CJ.2016.0076. No abstract available.

40.

Centrilobular nodules in high resolution computed tomography of the lung in IPAH patients - preliminary data concerning clinico-radiological correlates.

Szturmowicz M, Kacprzak A, Burakowska B, Skoczylas A, Bestry I, Kuś J, Fijałkowska A, Torbicki A, Kurzyna M.

Pneumonol Alergol Pol. 2016;84(5):265-70. doi: 10.5603/PiAP.2016.0033.

41.

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O.

Chest. 2017 Jan;151(1):106-118. doi: 10.1016/j.chest.2016.08.1473. Epub 2016 Sep 23. Erratum in: Chest. 2018 May;153(5):1287.

42.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM; ESC Scientific Document Group.

Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26. No abstract available. Erratum in: Eur Heart J. 2016 Dec 24;:.

43.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S; Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers.

Eur J Heart Fail. 2017 Jan;19(1):9-42. doi: 10.1002/ejhf.654. Epub 2016 Aug 27. Review. No abstract available.

44.

Vena cava superior stenting for rescue treatment of critical stenosis related to progressing cancer disease.

Darocha S, Szmit S, Pietura R, Torbicki A, Kurzyna M.

Kardiol Pol. 2016;74(6):601. doi: 10.5603/KP.2016.0094. No abstract available.

45.

Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.

Szturmowicz M, Kacprzak A, Franczuk M, Burakowska B, Kurzyna M, Fijałkowska A, Skoczylas A, Wesołowski S, Kuś J, Torbicki A.

Pneumonol Alergol Pol. 2016;84(2):87-94. doi: 10.5603/PiAP.2016.0006.

46.

Hypertension: Definition of pulmonary hypertension challenged?

Torbicki A.

Nat Rev Cardiol. 2016 May;13(5):250-1. doi: 10.1038/nrcardio.2016.44. Epub 2016 Mar 24. No abstract available.

PMID:
27009424
47.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002. No abstract available.

PMID:
26837729
48.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G.

Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.

PMID:
26826181
49.

Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry.

Koć M, Kostrubiec M, Elikowski W, Meneveau N, Lankeit M, Grifoni S, Kuch-Wocial A, Petris A, Zaborska B, Stefanović BS, Hugues T, Torbicki A, Konstantinides S, Pruszczyk P; RiHTER Investigators.

Eur Respir J. 2016 Mar;47(3):869-75. doi: 10.1183/13993003.00819-2015. Epub 2016 Jan 21.

50.

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Kardiol Pol. 2015;73(12):1127-206. doi: 10.5603/KP.2015.0242. Polish. No abstract available.

Supplemental Content

Loading ...
Support Center